Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Galam is a global leader in the production of sugar-based ingredients and prebiotic fibers for the food, nutraceutical, and pharmaceutical industries. The company is best known for its GOFOS brand, a short-chain fructo-oligosaccharide (sc-FOS) produced from beet sugar using a proprietary enzymatic process to support gut health and sugar reduction. Galam also manufactures crystalline fructose, glucose syrups, and pharmaceutical-grade excipients used in drug formulation. With over 80 years of experience, the company operates from its headquarters in Israel and maintains a strong international presence through subsidiaries and distribution partners. Its products are widely used in infant formula, dietary supplements, and health-focused food and beverage applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Galam.